tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Clorox to Acquire GOJO, Expanding Hygiene Portfolio

Story Highlights
  • Clorox agreed on January 22, 2026 to acquire GOJO, maker of Purell, for $2.25 billion in cash, expanding its reach in skin health and hygiene across B2B and retail channels.
  • Funded primarily with debt, the GOJO deal adds a large recurring B2B revenue base and at least $50 million in expected cost synergies, with Clorox forecasting growth and margin accretion while reaffirming its fiscal 2026 outlook.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Clorox to Acquire GOJO, Expanding Hygiene Portfolio

Claim 50% Off TipRanks Premium

Clorox ( (CLX) ) has shared an announcement.

On January 22, 2026, Clorox announced a definitive agreement to acquire GOJO Industries, maker of the Purell skin hygiene brand, for $2.25 billion in cash, implying a net purchase price of $1.92 billion after anticipated tax benefits and valuing the deal at an adjusted EBITDA multiple of 11.9x, or 9.1x including projected cost synergies. GOJO, which generates nearly $800 million in annual sales and derives more than 80% of its revenue through a broad B2B distributor network anchored by roughly 20 million installed dispensers, will expand Clorox’s presence in high-growth health and hygiene categories and strengthen its professional and institutional offerings while keeping GOJO’s operations based in Ohio. Clorox plans to fund the acquisition primarily with debt, expects at least $50 million in run-rate cost synergies, and projects the transaction will add a recurring revenue stream, be accretive to growth and adjusted EBITDA margins after synergies, and turn accretive to adjusted EPS in the second year, while reaffirming its standalone fiscal 2026 sales and earnings outlook as it pursues its IGNITE strategy and leverages its scale to accelerate Purell’s retail growth and build a best-in-class B2B hygiene platform.

The most recent analyst rating on (CLX) stock is a Sell with a $109.00 price target. To see the full list of analyst forecasts on Clorox stock, see the CLX Stock Forecast page.

Spark’s Take on CLX Stock

According to Spark, TipRanks’ AI Analyst, CLX is a Neutral.

Clorox’s overall stock score is driven by strong profitability and a fair valuation, but is tempered by financial instability, bearish technical indicators, and mixed earnings call sentiment. The company’s high leverage and recent operational disruptions pose significant risks.

To see Spark’s full report on CLX stock, click here.

More about Clorox

The Clorox Company (NYSE: CLX) is a U.S.-based consumer products manufacturer headquartered in Oakland, California, with a portfolio spanning cleaning, health and wellness, household, and lifestyle brands, including Clorox, Brita, Glad, Kingsford, Burt’s Bees and others. The company focuses on consumer-centric innovation and sustainability and has been increasingly emphasizing its Health and Wellness segment as a core growth engine, targeting both retail consumers and institutional customers in sectors such as healthcare, education and foodservice.

Average Trading Volume: 2,297,272

Technical Sentiment Signal: Sell

Current Market Cap: $13.4B

For a thorough assessment of CLX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1